PEPTONIC medical AB (publ) (XSAT:PMED)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.0600
0.00 (0.00%)
At close: Jan 31, 2024

PEPTONIC medical AB Statistics

Total Valuation

XSAT:PMED has a market cap or net worth of SEK 92.09 million. The enterprise value is 88.54 million.

Market Cap92.09M
Enterprise Value 88.54M

Important Dates

The last earnings date was Wednesday, August 19, 2026.

Earnings Date Aug 19, 2026
Ex-Dividend Date n/a

Share Statistics

XSAT:PMED has 1.53 billion shares outstanding.

Current Share Class 1.53B
Shares Outstanding 1.53B
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 4.64%
Owned by Institutions (%) 19.47%
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 8.41
PB Ratio 1.77
P/TBV Ratio 32.46
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 8.08
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.33, with a Debt / Equity ratio of 0.00.

Current Ratio 1.33
Quick Ratio 0.32
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF -0.01
Interest Coverage -5.06

Financial Efficiency

Return on equity (ROE) is -40.81% and return on invested capital (ROIC) is -19.22%.

Return on Equity (ROE) -40.81%
Return on Assets (ROA) -16.35%
Return on Invested Capital (ROIC) -19.22%
Return on Capital Employed (ROCE) -34.08%
Weighted Average Cost of Capital (WACC) 7.25%
Revenue Per Employee 5.48M
Profits Per Employee -10.50M
Employee Count2
Asset Turnover 0.16
Inventory Turnover 0.79

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -43.93% in the last 52 weeks. The beta is 0.00, so XSAT:PMED's price volatility has been lower than the market average.

Beta (5Y) 0.00
52-Week Price Change -43.93%
50-Day Moving Average 0.06
200-Day Moving Average 0.07
Relative Strength Index (RSI) 50.31
Average Volume (20 Days) 936,467

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, XSAT:PMED had revenue of SEK 10.95 million and -21.00 million in losses.

Revenue10.95M
Gross Profit 5.88M
Operating Income -17.74M
Pretax Income -21.00M
Net Income -21.00M
EBITDA -15.81M
EBIT -17.74M
Earnings Per Share (EPS) n/a
Full Income Statement

Balance Sheet

The company has 758,000 in cash and 105,000 in debt, with a net cash position of 653,000 or 0.00 per share.

Cash & Cash Equivalents 758,000
Total Debt 105,000
Net Cash 653,000
Net Cash Per Share 0.00
Equity (Book Value) 52.06M
Book Value Per Share n/a
Working Capital 2.57M
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures -31,000
Depreciation & Amortization 1.93M
Net Borrowing n/a
Free Cash Flow -9.67M
FCF Per Share -0.01
Full Cash Flow Statement

Margins

Gross margin is 53.66%, with operating and profit margins of -161.98% and -191.77%.

Gross Margin 53.66%
Operating Margin -161.98%
Pretax Margin -191.77%
Profit Margin -191.77%
EBITDA Margin -144.33%
EBIT Margin -161.98%
FCF Margin n/a

Dividends & Yields

XSAT:PMED does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -22.81%
FCF Yield -10.50%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1